Ausgabe 8/2023
Inhalt (13 Artikel)
Expanding the Role of Continuous Glucose Monitoring in Modern Diabetes Care Beyond Type 1 Disease
Tomasz Klupa, Leszek Czupryniak, Grzegorz Dzida, Piotr Fichna, Przemyslawa Jarosz-Chobot, Janusz Gumprecht, Malgorzata Mysliwiec, Agnieszka Szadkowska, Dorota Bomba-Opon, Krzysztof Czajkowski, Maciej T. Malecki, Dorota A. Zozulinska-Ziolkiewicz
Childhood Obesity and Essential Micronutrients: Insights from India’s Comprehensive National Nutrition Survey (2016–18)
Madhur Verma, Aditi Aditi, Nitin Kapoor, Priyanka Sharma, Monica Kakkar, Rakesh Kakkar, Sanjay Kalra
Emerging Adult and Caregiver Psychosocial Experiences with Severe Hypoglycemic Events and the Perceived Impact of Nasal Glucagon: A Cross-Sectional Study
Caitlin S. Kelly, Huyen Nguyen, Weixiu Luo, Katherine Chapman, Jiat-Ling Poon, Magaly Perez-Nieves, Levenia Baker, Wendy A. Wolf, Beth Mitchell
Real-World Effects of Second-Generation Versus Earlier Intermediate/Basal Insulin Analogues on Rates of Hypoglycemia in Adults with Type 1 and 2 Diabetes (iNPHORM, US)
Jason E. Black, Stewart B. Harris, Bridget L. Ryan, Guangyong Zou, Alexandria Ratzki-Leewing
Real-World User and Clinician Perspective and Experience with MiniMed™ 780G Advanced Hybrid Closed Loop System
Jothydev Kesavadev, Anjana Basanth, Gopika Krishnan, Arun Shankar, Geethu Sanal, Sunitha Jothydev
Clinical Benefits of Treating Patients with Type 2 Diabetes Mellitus with iGlarLixi: A Patient-Level Simulation Study
Ankita Chauhan, Mihail Samnaliev, Jennifer Ken-Opurum, Sistla S. S. Srinivas, Aashay M. Mehta, Terry Dex, Scott Charland, Andrew Revel, Ronald Preblick
A Qualitative Research Study of Experiences and Perceptions of People Living with Insulin Resistance Syndrome or Lipoatrophic Diabetes in Japan
Nobutaka Yagi, Akiko Toda, Kimiko Mitani, Yutaro Kotobuki, Wataru Ogawa
Atherosclerotic Cardiovascular Disease in Type 2 Diabetes: A Retrospective, Observational Study of Economic and Clinical Burden in Sweden
Katarina Steen Carlsson, Mads Faurby, Kristoffer Nilsson, Michael Lyng Wolden
Time in Range Estimation in Patients with Type 2 Diabetes is Improved by Incorporating Fasting and Postprandial Glucose Levels
Rui Sun, Yanli Duan, Yumei Zhang, Lingge Feng, Bo Ding, Rengna Yan, Jianhua Ma, Xiaofei Su
Pharmacokinetics and Safety of iGlarLixi in Healthy Chinese Participants: Results of a Phase 1 Randomized Study
Panpan Xie, Xuemei He, Xin Gao, Mengmeng Shuai, Wolfgang Schmider, Alex Jiang, Na Yang, Aixin Shi
Healthcare Professionals’ Knowledge of and Attitudes Towards the Use of Time in Range in Diabetes Management: Online Survey Across Seven Countries
Christophe De Block, Alice Y. Y. Cheng, Trine Brandt Christensen, Usha Rani H. Patted, Anna Ginovker
Greater Combined Reductions of HbA1c ≥ 1.0% and Body Weight Loss ≥ 5.0% or ≥ 10.0% with Orally Administered Semaglutide Versus Comparators
Kathleen M. Dungan, Lars Bardtrum, Erik Christiansen, Johanna Eliasson, Linda Mellbin, Vincent C. Woo, Tina Vilsbøll
Circulating Cytokine Levels and Cardiovascular Disease Risk Profile in Young Adult Offspring of Women with Type 1 Diabetes
Erik Somersalo, Krista Kuuliala, Antti Kuuliala, Niko S. Wasenius, Miira M. Klemetti, Anne S. Kivimäki, Hannu Kautiainen, Johan G. Eriksson, Merja K. Laine